Macy’s CEO Jeff Gennette, who’s led the company’s turnaround effort, will retire next year

Macy’s CEO Jeff Gennette, who’s led the company’s turnaround effort, will retire next year


Jeff Gennette, CEO of Macy’s.

Getty Images

Macy’s CEO Jeff Gennette will retire early next year after a four-decade career at the company, the department store chain announced Wednesday morning.

Gennette, 61, plans to step down in February. He will be succeeded by Tony Spring, CEO of the company’s higher-end department store banner, Bloomingdale’s.

In addition to the CEO change, Macy’s Chief Financial Officer Adrian Mitchell will take on an expanded role and also serve as the company’s chief operating officer. He will lead store operations, technology and supply chain teams, along with his existing role over finance and real estate.

When Gennette stepped into Macy’s top role in 2017, he faced declining sales and hard questions of whether the storied retailer — and department stores in general — could survive as customers moved online and increasingly shopped at discounters, e-commerce players and fashion-forward brands.

He spearheaded efforts to reinvigorate the nearly 165-year-old company. He kicked off Macy’s three-year turnaround plan, called Polaris, announced in February 2020. It called for accelerating digital growth, closing underperforming shops and investing in the company’s best stores to boost profits.

Over the past three years, Gennette navigated the company through another major challenge: A pandemic that forced Macy’s to temporarily shutter its nearly 800 stores and furlough the majority of its employees.

The retailer emerged from the pandemic with a smaller workforce and store footprint, but with less debt and more modern, data-driven organization.

Shares of the company have fallen about 50% since March 2017, when Gennette took over the top job, but the stock has rebounded dramatically from lows in March and April 2020, just after Covid was designated a pandemic.

Last year, the retailer managed to avoid the inventory woes of many of its retail peers — setting it up better for the holiday season and start of the fiscal year. It has recently broken from its typical role of shopping mall anchor by opening and testing several smaller and off-mall locations.

Gennette has also stood out as an openly gay leader of a publicly traded company. He has been a vocal champion of equal rights, such as publicly backing and expressing company support for the Respect for Marriage Act.

In a news release, Macy’s said Spring, 58, was tapped as its next leader after an internal and external search.

Bloomingdale’s, which Spring currently leads, has been one of the strongest parts of Macy’s business. The banner, which has fewer stores, but more luxury brands and bigger-spending customers, outperformed Macy’s namesake banner during each quarter of the past fiscal year.

The company also includes beauty banner Bluemercury, which Spring also helped reposition into another bright spot for the company.

Gennette praised Spring’s performance.

“Tony consistently innovates for the customer, is an exceptional brand builder and an excellent talent developer who has strengthened our culture through his leadership,” he said in a new release.

Gennette called Spring and Mitchell “an ideal team to build on our momentum and propel Macy’s, Inc. into the future.”



Source

Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More
Trump administration moves to reclassify cannabis in major shift that could expand research
Business

Trump administration moves to reclassify cannabis in major shift that could expand research

The Trump administration moved Thursday to reclassify cannabis under federal law, which could significantly expand scientific research into the drug’s medical uses. The change would not legalize the drug at the federal level, but shift cannabis from its current status as a Schedule I substance to Schedule III under the U.S. Drug Enforcement Administration’s controlled […]

Read More
Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
Business

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026 in Washington, DC. Alex Wong | Getty Images Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White […]

Read More